Compare Lupin Ltd with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs ORCHID PHARMA LTD - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN ORCHID PHARMA LTD LUPIN/
ORCHID PHARMA LTD
 
P/E (TTM) x 105.7 -0.5 - View Chart
P/BV x 2.4 0.1 2,037.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LUPIN   ORCHID PHARMA LTD
EQUITY SHARE DATA
    LUPIN
Mar-19
ORCHID PHARMA LTD
Sep-13
LUPIN/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs986194 508.2%   
Low Rs72035 2,058.3%   
Sales per share (Unadj.) Rs369.5276.5 133.6%  
Earnings per share (Unadj.) Rs13.4-79.2 -16.9%  
Cash flow per share (Unadj.) Rs37.4-43.5 -86.0%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs303.753.9 563.1%  
Shares outstanding (eoy) m452.4970.45 642.3%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x2.30.4 557.6%   
Avg P/E ratio x63.6-1.4 -4,403.2%  
P/CF ratio (eoy) x22.8-2.6 -866.1%  
Price / Book Value ratio x2.82.1 132.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m386,0648,067 4,786.0%   
No. of employees `00017.72.8 631.6%   
Total wages/salary Rs m31,5132,527 1,247.0%   
Avg. sales/employee Rs Th9,453.86,956.1 135.9%   
Avg. wages/employee Rs Th1,782.0902.5 197.5%   
Avg. net profit/employee Rs Th343.0-1,993.0 -17.2%   
INCOME DATA
Net Sales Rs m167,18219,477 858.4%  
Other income Rs m3,640407 894.0%   
Total revenues Rs m170,82219,884 859.1%   
Gross profit Rs m28,8221,103 2,614.0%  
Depreciation Rs m10,8502,519 430.7%   
Interest Rs m3,0785,227 58.9%   
Profit before tax Rs m18,534-6,236 -297.2%   
Minority Interest Rs m-8920 -453.3%   
Prior Period Items Rs m380-   
Extraordinary Inc (Exp) Rs m-3,400511 -665.3%   
Tax Rs m9,017-125 -7,202.0%   
Profit after tax Rs m6,066-5,580 -108.7%  
Gross profit margin %17.25.7 304.5%  
Effective tax rate %48.72.0 2,423.3%   
Net profit margin %3.6-28.7 -12.7%  
BALANCE SHEET DATA
Current assets Rs m138,53611,014 1,257.8%   
Current liabilities Rs m61,29932,060 191.2%   
Net working cap to sales %46.2-108.1 -42.8%  
Current ratio x2.30.3 657.8%  
Inventory Days Days8495 88.3%  
Debtors Days Days11234 335.1%  
Net fixed assets Rs m127,51629,440 433.1%   
Share capital Rs m905705 128.5%   
"Free" reserves Rs m136,5172,043 6,683.5%   
Net worth Rs m137,4223,800 3,616.5%   
Long term debt Rs m66,4179,018 736.5%   
Total assets Rs m279,49446,510 600.9%  
Interest coverage x7.0-0.2 -3,635.5%   
Debt to equity ratio x0.52.4 20.4%  
Sales to assets ratio x0.60.4 142.8%   
Return on assets %3.3-0.8 -430.4%  
Return on equity %4.4-146.9 -3.0%  
Return on capital %8.9-3.7 -238.6%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m59,4147,513 790.8%   
Fx outflow Rs m22,2825,649 394.5%   
Net fx Rs m37,1321,865 1,991.5%   
CASH FLOW
From Operations Rs m16,6601,682 990.6%  
From Investments Rs m-32,825-9,860 332.9%  
From Financial Activity Rs m7,4416,644 112.0%  
Net Cashflow Rs m-8,724-1,535 568.3%  

Share Holding

Indian Promoters % 46.6 32.3 144.3%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 4.6 245.7%  
FIIs % 31.9 3.3 966.7%  
ADR/GDR % 0.0 4.6 -  
Free float % 10.1 55.3 18.3%  
Shareholders   98,259 84,811 115.9%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  FULFORD INDIA  ALKEM LABORATORIES  ELDER PHARMA  

Compare LUPIN With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 229 Points Lower; Banking and Metal Stocks Witness Selling(Closing)

Indian share markets fell sharply during closing hours today amid weak global cues and disappointing domestic factory output data.

Related Views on News

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Nov 13, 2019 03:37 PM

TRACK LUPIN

LUPIN - PROCTER & GAMBLE HEALTH COMPARISON

COMPARE LUPIN WITH

MARKET STATS